Stage IVC Papillary Thyroid Cancer
4 clinical trials · Condition
◉ Watch Stage IVC Papillary Thyroid Cancer
| Record | Firm | Date |
|---|---|---|
| Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery (NCT01413113) | University of Washington | 2011-12-01 |
| Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer (NCT00519896) | University of Washington | 2007-07-01 |
| Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131 (NCT00085293) | National Cancer Institute (NCI) | 2004-05-01 |
| Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer (NCT00068497) | National Cancer Institute (NCI) | 2003-08-01 |
Track Stage IVC Papillary Thyroid Cancer automatically
Every clearance here is in the API, with alerts when new ones post.